Assessment of a transfusion emergent risk: The case of HEV;Estimation d'un risque transfusionnel émergent: L'exemple du VHE

Transfusion Clinique et Biologique

Volumn 21, Issue 4-5, 2014, Pages 162-166

  Pillonel, J ^a   Gallian, P ^b   Sommen, C ^a   Couturier, E ^a   Piquet, Y ^b   Djoudi, R ^b   Laperche, S ^c  

^a INSTITUT DE VEILLE SANITAIRE   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

Author keywords

Blood transfusion; HEV; Risk assessment

Indexed keywords

VIRUS RNA;

AGE; ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; BLOOD TRANSFUSION; DEMOGRAPHY; FRANCE; HEPATITIS E VIRUS; HUMAN; INFECTION RISK; NONHUMAN; RISK ASSESSMENT; RISK FACTOR; SEROPREVALENCE; SEX DIFFERENCE; VIRAL CONTAMINATION; VIRUS TRANSMISSION; ADVERSE EFFECTS; BLOOD; BLOOD SAFETY; COMMUNICABLE DISEASES, EMERGING; DONOR SELECTION; EUROPE; FEMALE; GENETICS; HEALTH; HEPATITIS E; ISOLATION AND PURIFICATION; MALE; PLASMA; PROCEDURES; RISK; STANDARDS; TRANSMISSION; VIREMIA; VIROLOGY;

BLOOD DONORS; BLOOD SAFETY; BLOOD TRANSFUSION; COMMUNICABLE DISEASES, EMERGING; DONOR SELECTION; EUROPE; FEMALE; FRANCE; GLOBAL HEALTH; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; MALE; PLASMA; RISK; RISK ASSESSMENT; RNA, VIRAL; VIREMIA;

EID: 84928721794     PISSN: 12467820     EISSN: 19538022     Source Type: Journal    
DOI: 10.1016/j.tracli.2014.07.004     Document Type: Article

References (28)

1. Courouce A.M. [HIV seropositivity in blood donors from 1990 to 1992: prevalence, estimation of residual risk of transfusion-related infections and epidemiology]. Rev Fr Transfus Hemobiol 1993, 36:327-337.
2. Brouard C., De Valk H., Pillonel J., Assal A., Bernillon P., Vaillant V., et al. Estimation quantitative du risque de contamination d'un don de sang par des agents infectieux. Groupe de travail Afssaps, EFS, INTS, InVS 2007, Institut de veille sanitaire, Saint-Maurice, [79p].
3. Pillonel J., Brouard C., Laperche S., Barin F., Bernillon P., de V.H. [Quantitative estimate of the risk of blood donation contamination by infectious agents]. Transfus Clin Biol 2009, 16:138-145.
4. Andonov A., Rock G., Lin L., Borlang J., Hooper J., Grudeski E., et al. Serological and molecular evidence of a plausible transmission of hepatitis E virus through pooled plasma. Vox Sang 2014, 10.1111/vox.12156.
5. Arankalle V.A., Chobe L.P. Retrospective analysis of blood transfusion recipients: evidence for post-transfusion hepatitis E. Vox Sang 2000, 79:72-74.
6. Boxall E., Herborn A., Kochethu G., Pratt G., Adams D., Ijaz S., et al. Transfusion-transmitted hepatitis E in a "non-hyperendemic" country. Transfus Med 2006, 16:79-83.
7. Colson P., Coze C., Gallian P., Henry M., De M.P., Tamalet C. Transfusion-associated hepatitis E, France. Emerg Infect Dis 2007, 13:648-649.
8. Matsubayashi K., Nagaoka Y., Sakata H., Sato S., Fukai K., Kato T., et al. Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion 2004, 44:934-940.
9. Matsubayashi K., Kang J.H., Sakata H., Takahashi K., Shindo M., Kato M., et al. A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion 2008, 48:1368-1375.
10. Piquet Y. Validation d'un test de dépistage de l'ARN du VHE dans le cadre de la prévention de la transmission par le PFC-SD. XXVI congrès de la SFTS 2013.
11. Abravanel F., Chapuy-Regaud S., Lhomme S., Miedouge M., Peron J.M., Alric L., et al. Performance of anti-HEV assays for diagnosing acute hepatitis E in immunocompromised patients. J Clin Virol 2013, 58:624-628.
12. Abravanel F., Chapuy-Regaud S., Lhomme S., Dubois M., Peron J.M., Alric L., et al. Performance of two commercial assays for detecting hepatitis E virus RNA in acute or chronic infections. J Clin Microbiol 2013, 51:1913-1916.
13. Biggerstaff B.J., Petersen L.R. Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City. Transfusion 2002, 42:1019-1026.
14. Beale M.A., Tettmar K., Szypulska R., Tedder R.S., Ijaz S. Is there evidence of recent hepatitis E virus infection in English and North Welsh blood donors?. Vox Sang 2011, 100:340-342.
15. Boutrouille A., Bakkali-Kassimi L., Cruciere C., Pavio N. Prevalence of anti-hepatitis E virus antibodies in French blood donors. J Clin Microbiol 2007, 45:2009-2010.
16. Dreier J., Juhl D. Autochthonous hepatitis e virus infections: a new transfusion-associated risk?. Transfus Med Hemother 2014, 41:29-39.
17. Faramawi M.F., Johnson E., Chen S., Pannala P.R. The incidence of hepatitis E virus infection in the general population of the USA. Epidemiol Infect 2011, 139:1145-1150.
18. Ijaz S., Vyse A.J., Morgan D., Pebody R.G., Tedder R.S., Brown D. Indigenous hepatitis E virus infection in England: more common than it seems. J Clin Virol 2009, 44:272-276.
19. Juhl D., Baylis S.A., Blumel J., Gorg S., Hennig H. Seroprevalence and incidence of hepatitis E virus infection in German blood donors. Transfusion 2014, 54:49-56.
20. Kamar N., Dalton H.R., Abravanel F., Izopet J. Hepatitis E virus infection. Clin Microbiol Rev 2014, 27:116-138.
21. Mansuy J.M., Legrand-Abravanel F., Calot J.P., Peron J.M., Alric L., Agudo S., et al. High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France. J Med Virol 2008, 80:289-293.
22. Faber M.S., Wenzel J.J., Jilg W., Thamm M., Hohle M., Stark K. Hepatitis E virus seroprevalence among adults. Germany. Emerg Infect Dis 2012, 18:1654-1657.
23. Hogema B.M., Molier M., Slot E., Zaaijer H.L. Past and present of hepatitis E in the Netherlands. Transfusion 2014, 10.1111/trf.12733.
24. Baylis S.A., Gartner T., Nick S., Ovemyr J., Blumel J. Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States. Vox Sang 2012, 103:89-90.
25. Corman V.M., Drexler J.F., Eckerle I., Roth W.K., Drosten C., Eis-Hubinger A.M. Zoonotic hepatitis E virus strains in German blood donors. Vox Sang 2013, 104:179-180.
26. Ijaz S., Szypulska R., Tettmar K.I., Kitchen A., Tedder R.S. Detection of hepatitis E virus RNA in plasma mini-pools from blood donors in England. Vox Sang 2012, 102:272.
27. Slot E., Hogema B.M., Riezebos-Brilman A., Kok T.M., Molier M., Zaaijer H.L. Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012. Euro Surveill 2013, 18. [pii: 20550].
28. Vollmer T., Diekmann J., Johne R., Eberhardt M., Knabbe C., Dreier J. Novel approach for detection of hepatitis E virus infection in German blood donors. J Clin Microbiol 2012, 50:2708-2713.